To the best of our knowledge, the present study that was performed on the Egyptian cohort is the first which assesses the expression level of circulating miRNA-373 and its target genes including VEGF and cyclin D1 in blood specimens of BC patients. The gene discussed is CCND1; the disease is breast cancer.